Tingting Lv

Dr. Tingting Lv

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YWYifei Wang
Yifei Wang
QLQing Li
Qing Li
LBLei Bi
Lei Bi
BWBin Wang
Bin Wang
TLTingting Lv
Tingting Lv
PZPing Zhang
Ping Zhang
Ischemic heart disease (IHD) remains a leading cause of mortality and morbidity globally. This study aims to evaluate the trends in IHD burden across different socioeconomic regions using data from the Global Burden of Disease Study 2021 (GBD 2021) and to understand the impact of the metabolic risk factors on these trends. Data from GBD 2021 was analyzed to evaluate the global age-standardized death rates (ASDR) and disability-adjusted life years (ASRDALYs) linked to IHD. Key metabolic risk factors evaluated included high systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDLc), fasting plasma glucose (FPG), and body mass index (BMI). Temporal trends were assessed using estimated annual percentage changes (EAPCs), with further analysis by age, sex and socio-demographic index (SDI). Resource-abundant regions showed notable reductions in ASDR and ASRDALYs, largely due to effective management of SBP and LDLc, resulting in an EAPC of -3.43 (95% CI: -3.32, -3.53). In contrast, resource-limited regions, particularly among males, experienced stagnation or even increases in IHD burden. The EAPC of ASDR in low-, low-middle-, and middle-SDI regions ranged from − 0.12 (95% CI: -0.04, -0.19) to 0.16 (95% CI: 0.09, 0.23). Among males, the values ranged from 0.22 (95% CI: 0.14, 0.29) to 0.55 (95% CI: 0.47, 0.62). The increase in IHD burden in these regions was primarily driven by rising levels of FPG and BMI. Younger populations (15–49 years) were disproportionately affected, showing increasing exposure to these metabolic risks. Regional disparities in IHD burden persist, primarily driven by metabolic risk factors. Resource-abundant regions have benefitted from effective control of SBP and LDLc, whereas resource-limited regions face growing challenges, especially related to FPG and BMI. The use of secondary data from the GBD 2021 database provides a comprehensive global perspective but may not fully capture local variations in disease burden. Targeted public health strategies and early interventions are essential to reduce the growing IHD burden in these vulnerable populations.

24 April 2025 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
YWYifei Wang
Yifei Wang
LBLei Bi
Lei Bi
QLQing Li
Qing Li
QWQiuyu Wang
Qiuyu Wang
TLTingting Lv
Tingting Lv
PZPing Zhang
Ping Zhang
The remnant cholesterol inflammatory index (RCII) is a novel metric that combines remnant cholesterol and high-sensitivity C-reactive protein, reflecting the metabolic and inflammatory risk. This study investigates the association between RCII and long-term risks of all-cause and cause-specific mortality in middle-aged and elderly populations in the US and China. We analyzed data from the National Health and Nutrition Examination Survey (NHANES) and the China Health and Retirement Longitudinal Study (CHARLS), including 7,565 and 12,932 participants aged 45 years and older, respectively. The participants were categorized into quartiles based on natural log-transformed RCII (lnRCII) values. Kaplan–Meier survival analysis, Cox proportional hazards models, restricted cubic splines (RCS) and mediation analysis were used to examine the relationship between lnRCII and mortality outcomes, adjusting for potential covariates. The mean age of the participants was 59.90 ± 10.44 years (NHANES) and 58.64 ± 9.78 years (CHARLS), with 53.28% and 52.50% female, respectively. Kaplan–Meier survival analysis showed that higher lnRCII quartiles (≥ 0.79 in NHANES, ≥ -0.13 in CHARLS) were significantly associated with increased all-cause mortality risk (p < 0.001). Each standard deviation (SD) increase in lnRCII corresponded to a higher risk of all-cause mortality, and the hazard ratios (HRs) and 95% confidence interval (CI) were 1.29 (95% CI: 1.21–1.36) in NHANES and 1.26 (95% CI: 1.15–1.38) in CHARLS. In NHANES, lnRCII was also associated with elevated risks of cardiovascular mortality (HR = 1.21, 95% CI: 1.08–1.35) and cancer mortality (HR = 1.30, 95% CI: 1.09–1.55). RCS analysis indicated a J-shaped relationship between lnRCII and both all-cause and cardiovascular mortality, and a linear association with cancer mortality. Mediation analysis showed that systolic blood pressure and fasting plasma glucose partially mediated these associations. Subgroup analyses suggested a stronger association between lnRCII and all-cause mortality in middle-aged US participants (p for interaction = 0.010). Elevated RCII levels are significantly associated with increased all-cause mortality risk middle-aged and elderly populations in both the US and China. In the US population, RCII is also associated with increased risks of cardiovascular and cancer mortality. By integrating metabolic and inflammatory risk factors, RCII may serve as a valuable tool for mortality risk stratification and clinical decision-making.

1 July 2018
Verified
Conference Paper
Closed access
PXPengwei Xie
Pengwei Xie
GWGuijin Wang
Guijin Wang
CZChenshuang Zhang
Chenshuang Zhang
MCMing Chen
Ming Chen
HYHuazhong Yang
Huazhong Yang
PZPing Zhang
Ping Zhang
We propose a novel electrocardiogram (ECG) beat classification algorithm using a combination of Bidirectional Recurrent Neural Network (BiRNN) and Convolutional Neural Network (CNN) named as BiRCNN. Our model is an end-to-end model. The morphological features of each ECG beat is extracted by CNN. Then the features of each beat are considered in the context via BiRNN. The assessment on MIT-BIH Arrhythmia Database (MITDB) resulted in a sensitivity of 98.7% and a positive predictivity of 96.4% on average for the VEB class. For the SVEB class, the sensitivity was 92.8%, which was an over 6% promotion compared with the state-of-the-art method, and the positive predictivity was 81.9% on average. The results demonstrate the superior classification performance of our method.

1 July 2018
Verified
Conference Paper
Closed access
MCMing Chen
Ming Chen
GWGuijin Wang
Guijin Wang
PXPengWei Xie
PengWei Xie
ZSZhenHua Sang
ZhenHua Sang
TLTingting Lv
Tingting Lv
HYHuazhong Yang
Huazhong Yang
Detection of ECG characteristic points serves as the first step in automated ECG analysis techniques. We propose a novel end-to-end deep learning scheme called Region Aggregation Network (RAN) for ECG characteristic points de- tection. A 1D Convolutional Neural Network (CNN) is adopted to automatically process ECG signals. A novel strategy of Region Aggregation is proposed to replace the conventional fully connected layer as regressor. Our work provides robust and accurate detection performance on public ECG database. The evaluation results of our method on QT database show comparable detection accuracy compared with state-of-the-art works.

30 April 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
PLPeng Liu
Peng Liu
TLTingting Lv
Tingting Lv
YYYing Yang
Ying Yang
QGQinggele Gao
Qinggele Gao
PZPing Zhang
Ping Zhang

8 July 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
YYYing Yang
Ying Yang
TLTingting Lv
Tingting Lv
SLSi‐Yuan Li
Si‐Yuan Li
PLPeng Liu
Peng Liu
QGQing‐Gele Gao
Qing‐Gele Gao
PZPing Zhang
Ping Zhang
Background: Diagnosis is particularly challenging in concealed or asymptomatic long QT syndrome (LQTS). Provocative testing, unmasking the characterization of LQTS, is a promising alternative method for the diagnosis of LQTS, but without uniform standards. Methods and Results: A comprehensive search was conducted in PubMed, Embase, and the Cochrane Library through October 14, 2021. The fixed effects model was used to assess the effect of the provocative testing on QTc interval. A total of 22 studies with 1137 patients with LQTS were included. At baseline, QTc interval was 40 ms longer in patients with LQTS than in controls (mean difference [MD], 40.54 [95% CI, 37.43–43.65]; P <0.001). Compared with the control group, patients with LQTS had 28 ms longer ΔQTc upon standing (MD, 28.82 [95% CI, 23.05–34.58]; P <0.001), nearly 30 ms longer both at peak exercise (MD, 27.31 [95% CI, 21.51–33.11]; P <0.001) and recovery 4 to 5 minutes (MD, 29.85 [95% CI, 24.36–35.35]; P <0.001). With epinephrine infusion, QTc interval was prolonged both in controls and patients with QTS, most obviously in LQT1 (MD, 68.26 [95% CI, 58.91–77.60]; P <0.001) and LQT2 (MD, 60.17 [95% CI, 50.18–70.16]; P <0.001). Subgroup analysis showed QTc interval response to abrupt stand testing and exercise testing varied between LQT1, LQT2, and LQT3, named Type Ⅰ, Type Ⅱ, and Type Ⅲ. Conclusions: QTc trend Type Ⅰ and Type Ⅲ during abrupt stand testing and exercise testing can be used to propose a prospective evaluation of LQT1 and LQT3, respectively. Type Ⅱ QTc trend combined epinephrine infusion testing could distinguish LQT2 from control. A preliminary diagnostic workflow was proposed but deserves further evaluation.